Cargando…

Inflammatory biomarkers and nanotechnology: new insights in pancreatic cancer early detection

BACKGROUND: Poor prognosis of pancreatic ductal adenocarcinoma (PDAC) is mainly due to the lack of effective early-stage detection strategies. Even though the link between inflammation and PDAC has been demonstrated and inflammatory biomarkers proved their efficacy in predicting several tumours, to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caputo, Damiano, Quagliarini, Erica, Coppola, Alessandro, La Vaccara, Vincenzo, Marmiroli, Benedetta, Sartori, Barbara, Caracciolo, Giulio, Pozzi, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583897/ https://www.ncbi.nlm.nih.gov/pubmed/37352522 http://dx.doi.org/10.1097/JS9.0000000000000558

Ejemplares similares

Detection of Pancreatic Ductal Adenocarcinoma by Ex Vivo Magnetic Levitation of Plasma Protein-Coated Nanoparticles
por: Digiacomo, Luca, et al.
Publicado: (2021)

Nanotechnology Meets Oncology: A Perspective on the Role of the Personalized Nanoparticle-Protein Corona in the Development of Technologies for Pancreatic Cancer Detection
por: Caputo, Damiano, et al.
Publicado: (2022)

Stratifying Risk for Pancreatic Cancer by Multiplexed Blood Test
por: Digiacomo, Luca, et al.
Publicado: (2023)

Nanotechnology and pancreatic cancer management: State of the art and further perspectives
por: Caputo, Damiano, et al.
Publicado: (2021)

Magnetic Levitation of Personalized Nanoparticle–Protein Corona as an Effective Tool for Cancer Detection
por: Quagliarini, Erica, et al.
Publicado: (2022)

Synergistic Analysis of Protein Corona and Haemoglobin Levels Detects Pancreatic Cancer
por: Caputo, Damiano, et al.
Publicado: (2020)

Multiplexed Detection of Pancreatic Cancer by Combining a Nanoparticle-Enabled Blood Test and Plasma Levels of Acute-Phase Proteins
por: Caputo, Damiano, et al.
Publicado: (2022)

Magnetic Levitation Patterns of Microfluidic-Generated Nanoparticle–Protein Complexes
por: Digiacomo, Luca, et al.
Publicado: (2022)

Personalized Graphene Oxide-Protein Corona in the Human Plasma of Pancreatic Cancer Patients
por: Di Santo, Riccardo, et al.
Publicado: (2020)

Role of Neoplastic Markers in Pancreatic Adenocarcinoma
por: Coppola, Alessandro, et al.
Publicado: (2022)

Preoperative systemic inflammatory biomarkers and postoperative day 1 drain amylase value predict grade C pancreatic fistula after pancreaticoduodenectomy
por: Caputo, Damiano, et al.
Publicado: (2020)

New Frontiers of Early Diagnosis of Pancreatic Fistula after Pancreaticoduodenectomy
por: Coppola, Alessandro, et al.
Publicado: (2022)

Postoperative procalcitonin is a biomarker for excluding the onset of clinically relevant pancreatic fistula after pancreaticoduodenectomy
por: Coppola, Alessandro, et al.
Publicado: (2023)

The influence of protein corona on Graphene Oxide: implications for biomedical theranostics
por: Quagliarini, Erica, et al.
Publicado: (2023)

Special Issue “Hepatobiliary and Pancreatic Cancers: Novel Strategies for of Diagnosis and Treatments”
por: Coppola, Alessandro, et al.
Publicado: (2022)

Mechanistic Insights into the Release of Doxorubicin from Graphene Oxide in Cancer Cells
por: Quagliarini, Erica, et al.
Publicado: (2020)

Protein Corona Fingerprints of Liposomes: New Opportunities for Targeted Drug Delivery and Early Detection in Pancreatic Cancer
por: Palchetti, Sara, et al.
Publicado: (2019)

Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives
por: Coppola, Alessandro, et al.
Publicado: (2022)

CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis
por: Coppola, Alessandro, et al.
Publicado: (2021)

Neoadjuvant Treatments for Pancreatic Ductal Adenocarcinoma: Where We Are and Where We Are Going
por: Coppola, Alessandro, et al.
Publicado: (2023)

Utility of preoperative systemic inflammatory biomarkers in predicting postoperative complications after pancreaticoduodenectomy: Literature review and single center experience
por: Coppola, Alessandro, et al.
Publicado: (2021)

Right hepatic artery anomalies in pancreatoduodenectomy—a risk for arterial resection but not for postoperative outcomes
por: La Vaccara, Vincenzo, et al.
Publicado: (2023)

Effect of Protein Corona on The Transfection Efficiency of Lipid-Coated Graphene Oxide-Based Cell Transfection Reagents
por: Quagliarini, Erica, et al.
Publicado: (2020)

Validations of new cut-offs for surgical drains management and use of computerized tomography scan after pancreatoduodenectomy: The DALCUT trial
por: Caputo, Damiano, et al.
Publicado: (2022)

Inhibiting the Growth of 3D Brain Cancer Models with Bio-Coronated Liposomal Temozolomide
por: Perini, Giordano, et al.
Publicado: (2021)

Microfluidic Formulation of DNA-Loaded Multicomponent Lipid Nanoparticles for Gene Delivery
por: Quagliarini, Erica, et al.
Publicado: (2021)

Data of postoperative complications related to fibrinogen-to-albumin ratio in pancreatic resections()
por: La Vaccara, V., et al.
Publicado: (2022)

Different Biliary Microbial Flora Influence Type of Complications after Pancreaticoduodenectomy: A Single Center Retrospective Analysis
por: Coppola, Alessandro, et al.
Publicado: (2021)

Tailoring Lipid-Based Drug Delivery Nanosystems by Synchrotron Small Angle X-ray Scattering
por: Sartori, Barbara, et al.
Publicado: (2022)

The protein corona reduces the anticancer effect of graphene oxide in HER-2-positive cancer cells
por: Cui, Lishan, et al.
Publicado: (2022)

Comment on ‘Inflammatory biomarkers and nanotechnology: new insights in pancreatic cancer early detection’
por: Wang, Yao, et al.
Publicado: (2023)

Functionalized Mesoporous Thin Films for Biotechnology
por: Sartori, Barbara, et al.
Publicado: (2021)

A commentary on ‘Inflammatory biomarkers and nanotechnology: new insights in pancreatic cancer early detection’
por: Xu, Ruiyuan, et al.
Publicado: (2023)

Efficient Delivery of DNA Using Lipid Nanoparticles
por: Cui, Lishan, et al.
Publicado: (2022)

Combination Therapy with a Bispecific Antibody Targeting the hERG1/β1 Integrin Complex and Gemcitabine in Pancreatic Ductal Adenocarcinoma
por: Lottini, Tiziano, et al.
Publicado: (2023)

Principles for optimization and validation of mRNA lipid nanoparticle vaccines against COVID-19 using 3D bioprinting
por: Papi, Massimiliano, et al.
Publicado: (2022)

The Transformative Potential of Lipid Nanoparticle–Protein Corona for Next-Generation Vaccines and Therapeutics
por: Amici, Augusto, et al.
Publicado: (2023)

Nanotechnologies in Pancreatic Cancer Therapy
por: Manzur, Ayesha, et al.
Publicado: (2017)

Insight into the Prospects for Nanotechnology in Wheat Biofortification
por: Khan, Mohd. Kamran, et al.
Publicado: (2021)

µDrop: a system for high-throughput small-angle X-ray scattering measurements of microlitre samples
por: Haider, Richard, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v7i583665bv3k7j4ac3dcp0d6d